Skip to content

Reproductive health and research: oocyte procurement.

It became law on Oct 13, 2019.

CA AB 922 · Assembly Bill · 2019–2020

Stage
Became law
Started in
Assembly
Sponsor
1
Latest action
Oct 13, 2019

What it does

Existing law prohibits human oocytes or embryos from being acquired, sold, offered for sale, received, or otherwise transferred for valuable consideration for medical research or development of medical therapies, and prohibits payment in excess of the amount of reimbursement of direct expenses to be made to any research subject to encourage an individual to produce human oocytes for the purposes of medical research. Before obtaining informed consent from a subject for assisted oocyte production (AOP) or any alternative method of ovarian retrieval on a subject for the purpose of procuring oocytes for research or the development of medical therapies, existing law requires a physician and…

Read the full text

Where it stands

This bill passed and is now law.

  1. Introduced (Done)

  2. Committee (Done)

  3. Floor (Done)

  4. Law (Done)

    Oct 13, 2019

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

Where it goes next

Once a bill is decided, the questions are about what is done with it in California.

Work with this bill

Reproductive health and research: oocyte procurement. | 52